Detected ·
Waypoint Bio
——
Waypoint Bio raised $20M in Series A financing to develop AI-designed CAR-T cells for solid tumors, with three first-in-human trials planned targeting gastric, pancreatic, and colorectal cancers.
- Website
- waypointbio.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-05-27 16:07:43 UTC
- Signal ID
- a6a010ca-a5a0-4f5f-b74d-7aa493d7274f
As the API returns it
{
"id": "a6a010ca-a5a0-4f5f-b74d-7aa493d7274f",
"created_at": "2026-05-27T16:07:43.303870Z",
"company_name": "Waypoint Bio",
"company_website_url": "waypointbio.com",
"company_linkedin_url": "https://www.linkedin.com/company/waypoint-bio",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Waypoint Bio raised $20M in Series A financing to develop AI-designed CAR-T cells for solid tumors, with three first-in-human trials planned targeting gastric, pancreatic, and colorectal cancers.*"
}